Clinical trial
An Ambispective Cohort Study on the Prognosis and Its Influencing Factors of Borderline Personality Disorder
NCT06005779 is registered in ClinicalTrials.gov with Wuhan Mental Health Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Ambispective Cohort Study on the Prognosis and Its Influencing Factors of Borderline Personality Disorder
- Lead sponsor
- Wuhan Mental Health Centre
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 22, 2021
- Completion date
- September 30, 2024
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.